Does one of companies, with whom AMRI has supply agreement, has FDA approval date coming up shortly.
I read in an analyst report on AMRI that "A wild card is the pending FDA approval of an investigational drug (decision expected later this year). A favorable decision can have a positive impact on AMRI revenues"
Does anyone know what is the name of this company with whom AMRI has supply agreement (as it was not identified in that article).
It would be nice to see that report or even the section of that report that includes that reference. My understanding is that when AMRI's clients' drugs are approved, then that has the potential for AMRI to lock in longer term revenues and also help with capacity utilization.
At the same time, some current AMRI employees should comment here and provide some clues, if the information involved is in the public domain. I seem to remember that there used to be some comments by AMRI management about X Number of client drugs in Phase 3 etc